Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Blood|October 28, 2010
Novel therapeutic agents for B-cell lymphoma: developing rational combinationsCraig B Reeder, Stephen M Ansell
JAMA Oncology|March 30, 2018
Rituximab Maintenance Therapy After First-Line Induction Chemoimmunotherapy for Follicular LymphomaTalal Hilal, Jose F Leis, Craig B Reeder
Leukemia Research Reports|December 28, 2013
New diagnosis of multiple myeloma in a patient with mantle cell lymphoma: Shared genetic factors or simple coincidence?Mutende J Sikuyayenga, Craig B Reeder, Joseph R Mikhael
Annals of Hematology|March 24, 2018
Necrobiotic xanthogranuloma: a 30-year single-center experienceTalal Hilal, David J DiCaudo, Suzanne M Connolly, et al.
American Journal of Hematology|July 24, 2018
Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta-analysisTalal Hilal, Zhen Wang, Diana Almader-Douglas, et al.
International Journal of Surgery Case Reports|September 13, 2016
Hemophilic pseudotumor in a non-hemophilic patient treated with a hybrid procedure of preoperative embolization of the feeding arteries followed by surgical resection-A case reportSorcha Allen, Craig B Reeder, Mark J Kransdorf, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 8, 2012
Histologic remission of cardiac amyloidosis: a case reportMatthew R Nelson, Louis A Lanza, Craig B Reeder, et al.
Clinical Chemistry|September 27, 2002
Trimolecular complexes of lambda light chain dimers in serum of a patient with multiple myelomaRoshini S Abraham, M Cristine Charlesworth, Barbara A L Owen, et al.
Blood|February 15, 2012
Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosisJoseph R Mikhael, Steven R Schuster, Victor H Jimenez-Zepeda, et al.
British Journal of Haematology|June 29, 2011
The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological originMyron S Czuczman, Julie M Vose, Thomas E Witzig, et al.
Pageof 6